The Conventional Neurology Model—and Why It Breaks Down
A 58-year-old executive walks into a traditional neurology clinic with progressive memory loss, fatigue, and mild tremor. The neurologist orders an MRI—normal. Cognitive testing—borderline. The diagnosis: "mild cognitive impairment, probably age-related." The recommendation: wait and see, possibly memantine if it gets worse. Three months later, nothing has changed. He's still declining.
This isn't malpractice. It's the structural limitation of the appointment model. A 15-minute neurology visit is designed to rule in or out specific disease categories—Parkinson's, Alzheimer's, multiple sclerosis. It's not designed to ask the harder questions: Is his mitochondrial function compromised? Are his glymphatic clearance mechanisms failing during sleep? What's his metabolic state? What about chronic inflammation from an undiagnosed infection or autoimmune process? Does his dopamine system need support, or is the tremor driven by something else entirely?
That gap—between identifying a disease label and understanding the mechanism driving decline—is where integrative neurology lives.
What Integrative Actually Means
Integrative neurology doesn't mean crystals or acupuncture or "listening to your gut." It means that neurological health emerges from multiple systems, and sustainable change requires addressing all of them simultaneously. Four pillars:
- Advanced Diagnostics: Standard MRI is structural—it shows you a tumor or lesion. We use DTI with fiber tract reconstruction to map white matter connectivity. NeuroQuant gives us volumetric data on the hippocampus, amygdala, and cortical thickness—early warning signs for neurodegeneration. PET metabolic imaging shows us where the brain's energy production is failing. These aren't alternative tests; they're the neurological equivalent of getting a full metabolic panel instead of just checking glucose.
- Metabolic Medicine: The brain runs on fuel. If mitochondrial function is compromised, or if someone is stuck in metabolic dysfunction (high insulin, poor glucose handling, inadequate ketone production), no amount of cognitive training will work. We assess mitochondrial function, shift metabolic state through targeted nutrition and sometimes IV protocols like NAD+, and measure the effect.
- Regenerative and Cellular Therapies: Mesenchymal stem cells and exosomes aren't panaceas, but they have specific roles in reducing inflammation, promoting neurotropic signaling, and supporting brain recovery after injury. We use them strategically, not as a blanket intervention.
- Psychological and Neuroplastic Intervention: The brain changes through behavior. EMDR for trauma-driven neurological patterns, neurocoaching for executive function deficits, sleep optimization protocols—these aren't soft skills. They're neurobiology. We integrate them from the start, not as an afterthought.
Where Conventional Neurology Sees Labels, Integrative Sees Mechanisms
A 42-year-old woman presented with "chronic migraine with aura and cognitive decline." She'd seen three neurologists. She was on prophylactic migraine medication, antidepressants, and sleeping poorly. Her standard MRI was normal.
DTI showed reduced white matter integrity in frontal tracts. NeuroQuant volumetric mapping revealed early hippocampal atrophy—unexpected in a 42-year-old. PET metabolic imaging showed hypometabolism in the temporal lobe. Labs revealed elevated homocysteine, low B12 despite supplementation, and markers of systemic inflammation (high hsCRP, elevated TNF-α).
The mechanism wasn't "chronic migraine" as a primary disorder. It was neuroinflammation driven by metabolic dysfunction and B12 malabsorption from undetected pernicious anemia. She had vasomotor instability that migraines happened to express, but the real issue was mitochondrial stress and impaired one-carbon metabolism.
Treatment: B12 intramuscular (bypassing absorption issues), high-dose folate and methylated B vitamins, anti-inflammatory dietary shift (lower seed oils, specific micronutrient targeting), IV NAD+ to support mitochondrial function, and EMDR for trauma-related autonomic dysregulation she hadn't mentioned until asked directly.
Six months later: migraines nearly gone. Cognitive clarity returned. White matter integrity improved on repeat DTI. Hippocampal volume stabilized.
Conventional neurology wasn't wrong—she does have migraines. But it stopped at the label instead of asking why.
The Technical Work That Changes Outcomes
A standard neurology appointment can't do this work. It takes time to understand metabolic history, sleep architecture, trauma exposure, exercise capacity, and current pharmaceutical interactions. It takes advanced imaging to see what's actually happening at the tissue level. It takes lab work—sometimes a lot of it—to identify hidden drivers of decline.
And it takes follow-up. Once you've identified that someone's phospholipid membrane integrity is compromised, or that their astrocytic support of synaptic transmission is impaired, you measure the effect of intervention. You adjust. You iterate.
That's not alternative medicine. That's actually being thorough.
Who Needs This?
Anyone with a neurological or cognitive complaint that's been partially investigated but not fully resolved. Anyone experiencing decline they can't explain. Anyone who's been told "it's normal aging" when they know something's wrong. Anyone managing brain injury, chronic neuroinflammation, or early-stage neurodegeneration where the conventional neurology playbook isn't enough.
And anyone interested in cognitive optimization—maintaining or advancing function before decline shows up.
The threshold question isn't whether you have a disease label. It's whether standard neurology has given you answers that actually account for what you're experiencing. If it hasn't, there's a different way to think about this.